{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:26:11Z","timestamp":1791559571080,"version":"4.3.4"},"reference-count":78,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immunoproliferative small intestinal disease (IPSID) was recently added to the growing list of infectious pathogen-associated human lymphomas. Molecular and immunohistochemical studies demonstrated an association with Campylobacter jejuni. IPSID is a variant of the B-cell lymphoma of mucosa-associated lymphoid tissue (MALT), which involves mainly the proximal small intestine resulting in malabsorption, diarrhea, and abdominal pain. Geographically, IPSID is most prevalent in the Middle East and Africa. IPSID lymphomas reveal excessive plasma cell differentiation and produce truncated \u03b1 heavy chain proteins lacking the light chains as well as the first constant domain. The corresponding mRNA lacks the variable heavy chain (VH) and the constant heavy chain 1 (CH1) sequences and contains deletions as well as insertions of unknown origin. The encoding gene sequence reveals a deletion of V region and parts of CH1 domain. Cytogenetic studies demonstrated clonal rearrangements involving predominantly the heavy and light chain genes, including t(9;14) translocation involving the PAX5 gene. Early-stage IPSID responds to antibiotics (30%-70% complete remission). Most untreated IPSID patients progress to lymphoplasmacytic and immunoblastic lymphoma invading the intestinal wall and mesenteric lymph nodes, and may metastasize to a distant organ. IPSID lymphoma shares clinical, morphologic, and molecular features with MALT lymphoma, lymphoplasmacytic lymphoma, and plasma cell neoplasms.<\/jats:p>","DOI":"10.1182\/blood-2004-07-2755","type":"journal-article","created":{"date-parts":[[2004,11,13]],"date-time":"2004-11-13T01:24:27Z","timestamp":1100309067000},"page":"2274-2280","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":172,"title":["Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms"],"prefix":"10.1182","volume":"105","author":[{"given":"Tahseen","family":"Al-Saleem","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA; and the Division of Hematology\/Oncology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Al-Mondhiry","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA; and the Division of Hematology\/Oncology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223121390800_REF1","doi-asserted-by":"crossref","unstructured":"Azar HA. Cancer in Lebanon and the Near East. Cancer. 1962;15: 66-78.","DOI":"10.1002\/1097-0142(196201\/02)15:1<66::AID-CNCR2820150111>3.0.CO;2-G"},{"key":"2020021223121390800_REF2","doi-asserted-by":"crossref","unstructured":"Al-Saleem T, Zardawi IM. Primary lymphomas of the small intestine in Iraq: a pathological study of 145 cases. Histopathology. 1979;3: 89-106.","DOI":"10.1111\/j.1365-2559.1979.tb02986.x"},{"key":"2020021223121390800_REF3","unstructured":"Ramot B, Shahin N, Bubis JJ. Malabsorption syndrome in lymphoma of small intestine: a study of 13 cases. Isr Med J.1965;47: 221-226."},{"key":"2020021223121390800_REF4","unstructured":"Bull D. Alpha-chain disease and related small intestinal lymphoma: a memorandum. Geneva, Switzerland: World Health Organization. 1976;54: 615-624."},{"key":"2020021223121390800_REF5","doi-asserted-by":"crossref","unstructured":"Seligmann M, Danon F, Hurez D, Mihaesco E, Preud'homme JL. Alpha-chain disease: a new immunoglobulin abnormality. Science. 1968;162: 1396-1397.","DOI":"10.1126\/science.162.3860.1396"},{"key":"2020021223121390800_REF6","doi-asserted-by":"crossref","unstructured":"Isaacson PG. Gastrointestinal lymphoma. Hum Pathol.1994;25: 1020-1029.","DOI":"10.1016\/0046-8177(94)90060-4"},{"key":"2020021223121390800_REF7","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW. Tumors of Hematopoietic and Lymphoid Tissue. Lyon, France: IARC; 2001."},{"key":"2020021223121390800_REF8","doi-asserted-by":"crossref","unstructured":"Rambaud JC, Galian A, Matuchansky C, et al. Natural history of alpha-chain disease and the so-called Mediterranean lymphoma. Recent Results Cancer Res.1978;64: 271-276.","DOI":"10.1007\/978-3-642-81246-0_32"},{"key":"2020021223121390800_REF9","doi-asserted-by":"crossref","unstructured":"Bender SW, Danon F, Preud'homme JL, Posselt HG, Roettger P, Seligmann M. Gamma heavy chain disease simulating alpha chain disease. Gut. 1978;19: 1148-1152.","DOI":"10.1136\/gut.19.12.1148"},{"key":"2020021223121390800_REF10","doi-asserted-by":"crossref","unstructured":"Cho C, Linscheer WG, Bell R, Smith R. Colonic lymphoma producing alpha-chain disease protein. Gastroenterology. 1982;83: 121-126.","DOI":"10.1016\/S0016-5085(82)80296-5"},{"key":"2020021223121390800_","doi-asserted-by":"crossref","unstructured":"Coulbois J, Galian P, Galian A, Couteaux B, Danon F, Rambaud J. Gastric form of alpha chain disease. Gut. 1986;27: 719-725.","DOI":"10.1136\/gut.27.6.719"},{"key":"2020021223121390800_REF12","doi-asserted-by":"crossref","unstructured":"Florin-Christensen A, Doniach D, Newcomb PB. Alpha-chain disease with pulmonary manifestations. Br Med J.1974;2: 413-415.","DOI":"10.1136\/bmj.2.5916.413"},{"key":"2020021223121390800_REF13","doi-asserted-by":"crossref","unstructured":"Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med.2004;350: 213-215.","DOI":"10.1056\/NEJMp038200"},{"key":"2020021223121390800_REF14","doi-asserted-by":"crossref","unstructured":"Rambaud JC, Halphen M, Galian A, Tsapis A. Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and \u201cMediterranean\u201d lymphomas. Springer Semin Immunopathol.1990;12: 239-250.","DOI":"10.1007\/BF00197509"},{"key":"2020021223121390800_","unstructured":"Al-Saleem T. The pathology of immunoproliferative disease of the small intestine (IPSID): analysis of 206 cases of primary lymphomas of the small intestine [abstract]. Blood. 1997;90: 2506."},{"key":"2020021223121390800_REF16","doi-asserted-by":"crossref","unstructured":"Khojasteh A, Haghighi P. Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World. Am J Med.1990;89: 483-490.","DOI":"10.1016\/0002-9343(90)90380-V"},{"key":"2020021223121390800_REF17","unstructured":"Khojasten A. Immunopathology of the small intestine. In: Marsh MN, ed. Chichester, United Kingdom: John Wiley, 1987: 121-150."},{"key":"2020021223121390800_REF18","unstructured":"Fine KD, Stone MJ. Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol.1999;94: 1139-1152."},{"key":"2020021223121390800_REF19","doi-asserted-by":"crossref","unstructured":"Al-Mondhiry H. Primary lymphomas of the small intestine: east-west contrast. Am J Hematol.1986;22: 89-105.","DOI":"10.1002\/ajh.2830220114"},{"key":"2020021223121390800_REF20","doi-asserted-by":"crossref","unstructured":"Gilinsky NH, Novis BH, Wright JP, Dent DM, King H, Marks IN. Immunoproliferative small-intestinal disease: clinical features and outcome in 30 cases. Medicine (Baltimore). 1987;66: 438-446.","DOI":"10.1097\/00005792-198711000-00002"},{"key":"2020021223121390800_","doi-asserted-by":"crossref","unstructured":"Rambaud JC. Small intestinal lymphomas and alpha-chain disease. Clin Gastroenterol.1983;12: 743-766.","DOI":"10.1016\/S0300-5089(21)00604-0"},{"key":"2020021223121390800_REF22","doi-asserted-by":"crossref","unstructured":"Al-Bahrani ZR, Al-Mondhiry H, Bakir F, Al-Saleem T. Clinical and pathologic subtypes of primary intestinal lymphoma: experience with 132 patients over a 14-year period. Cancer. 1983;52: 1666-1672.","DOI":"10.1002\/1097-0142(19831101)52:9<1666::AID-CNCR2820520920>3.0.CO;2-P"},{"key":"2020021223121390800_REF23","doi-asserted-by":"crossref","unstructured":"Vassal K, Dutz W, Kohout E, Rezvani L. Immunoproliferative small intestinal disease with duodenojejunal lymphoma: radiologic changes. Am J Radiol.1980;135: 491-497.","DOI":"10.2214\/ajr.135.3.491"},{"key":"2020021223121390800_REF24","doi-asserted-by":"crossref","unstructured":"Ramos L, Marcos J, Illanas M, et al. Radiological characteristics of primary intestinal lymphoma of the \u201cMediterranean\u201d type: observations on twelve cases. Radiology. 1978;126: 379-385.","DOI":"10.1148\/126.2.379"},{"key":"2020021223121390800_REF25","doi-asserted-by":"crossref","unstructured":"Rogers P, Hill I, Sinclair-Smith C, Bowie M. Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy. Med Pediatr Oncol.1988;16: 128-131.","DOI":"10.1002\/mpo.2950160213"},{"key":"2020021223121390800_REF26","doi-asserted-by":"crossref","unstructured":"Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med.2004;350: 239-248.","DOI":"10.1056\/NEJMoa031887"},{"key":"2020021223121390800_REF27","doi-asserted-by":"crossref","unstructured":"Chang CS, Lin SF, Chen TP, et al. Leukemic manifestation in a case of alpha-chain disease with multiple polypoid intestinal lymphocytic lymphoma. Am J Hematol.1992;41: 209-214.","DOI":"10.1002\/ajh.2830410312"},{"key":"2020021223121390800_REF28","doi-asserted-by":"crossref","unstructured":"Al-Bahrani Z, Al-Saleem T, Al-Mondhiry H, et al. Alpha heavy chain disease (report of 18 cases from Iraq). Gut. 1978;19: 627-631.","DOI":"10.1136\/gut.19.7.627"},{"key":"2020021223121390800_","unstructured":"Doe WF. Alpha chain disease clinicopathological features and relationship to so-called Mediterranean lymphoma. Br J Cancer. 1975;31(suppl 2): 350-355."},{"key":"2020021223121390800_REF30","doi-asserted-by":"crossref","unstructured":"Ben-Ayed F, Halphen M, Najjar T, et al. Treatment of alpha chain disease: results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group. Cancer. 1989;63: 1251-1256.","DOI":"10.1002\/1097-0142(19890401)63:7<1251::AID-CNCR2820630704>3.0.CO;2-H"},{"key":"2020021223121390800_REF31","unstructured":"Doe WF, Danon F, Seligmann M. Immunodiagnosis of alpha chain disease. Clin Exp Immunol.1979;36: 189-197."},{"key":"2020021223121390800_REF32","doi-asserted-by":"crossref","unstructured":"Al-Saleem TI, Qadiry WA, Issa FS, King J. The immunoselection technic in laboratory diagnosis of alpha heavy-chain disease. Am J Clin Pathol.1979;72: 132-133.","DOI":"10.1093\/ajcp\/72.1.132a"},{"key":"2020021223121390800_REF33","unstructured":"Haber DA, Mayer RJ. Primary gastrointestinal lymphoma. Semin Oncol.1988;15: 154-169."},{"key":"2020021223121390800_REF34","doi-asserted-by":"crossref","unstructured":"Lucidarme D, Colombel JF, Brandtzaeg P, et al. Alpha-chain disease: analysis of alpha-chain protein and secretory component in jejunal fluid. Gastroenterology. 1993;104: 278-285.","DOI":"10.1016\/0016-5085(93)90863-8"},{"key":"2020021223121390800_REF35","doi-asserted-by":"crossref","unstructured":"Seligmann M, Mihaesco E, Preud'homme JL, Danon F, Brouet JC. Heavy chain diseases: current findings and concepts. Immunol Rev.1979;48: 145-167.","DOI":"10.1111\/j.1600-065X.1979.tb00302.x"},{"key":"2020021223121390800_REF36","unstructured":"Fakhfakh F, Mihaesco E, Ayadi H, Brouet JC, Tsapis A. Alpha heavy chain disease: molecular analysis of a new case. Presse Med.1993;22: 1047-1051."},{"key":"2020021223121390800_REF37","doi-asserted-by":"crossref","unstructured":"Tsapis A, Bentaboulet M, Pellet P, et al. The productive gene for alpha-H chain disease protein MAL is highly modified by insertion-deletion processes. J Immunol.1989;143: 3821-3827.","DOI":"10.4049\/jimmunol.143.11.3821"},{"key":"2020021223121390800_REF38","doi-asserted-by":"crossref","unstructured":"Fakhfakh F, Dellagi K, Ayadi H, et al. Alpha heavy chain disease alpha mRNA contain nucleotide sequences of unknown origins. Eur J Immunol.1992;22: 3037-3040.","DOI":"10.1002\/eji.1830221141"},{"key":"2020021223121390800_REF39","doi-asserted-by":"crossref","unstructured":"Bentaboulet M, Mihaesco E, Gendron MC, Brouet JC, Tsapis A. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region. Eur J Immunol.1989;19: 2093-2098.","DOI":"10.1002\/eji.1830191119"},{"key":"2020021223121390800_REF40","doi-asserted-by":"crossref","unstructured":"Cogne M, Preud'homme JL. Gene deletions force nonsecretory alpha-chain disease plasma cells to produce membrane-form alpha-chain only. J Immunol.1990;145: 2455-2458.","DOI":"10.4049\/jimmunol.145.8.2455"},{"key":"2020021223121390800_REF41","doi-asserted-by":"crossref","unstructured":"Teng MH, Rosen S, Gorny MK, Alexander A, Buxbaum J. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains. Blood Cells Mol Dis.2000;26: 177-185.","DOI":"10.1006\/bcmd.2000.0294"},{"key":"2020021223121390800_REF42","doi-asserted-by":"crossref","unstructured":"Alexander A, Anicito I, Buxbaum J. Gamma heavy chain disease in man: genomic sequence reveals two noncontiguous deletions in a single gene. J Clin Invest.1988;82: 1244-1252.","DOI":"10.1172\/JCI113722"},{"key":"2020021223121390800_REF43","doi-asserted-by":"crossref","unstructured":"Guglielmi P, Bakhshi A, Cogne M, Seligmann M, Korsmeyer SJ. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein. J Immunol.1988;141: 1762-1768.","DOI":"10.4049\/jimmunol.141.5.1762"},{"key":"2020021223121390800_REF44","doi-asserted-by":"crossref","unstructured":"Smith WJ, Price SK, Isaacson PG. Immunoglobulin gene rearrangement in immunoproliferative small intestinal disease (IPSID). J Clin Pathol.1987;40: 1291-1297.","DOI":"10.1136\/jcp.40.11.1291"},{"key":"2020021223121390800_REF45","doi-asserted-by":"crossref","unstructured":"Cogne M, Bakhshi A, Korsmeyer SJ, Guglielmi P. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease. J Immunol.1988;141: 1738-1744.","DOI":"10.4049\/jimmunol.141.5.1738"},{"key":"2020021223121390800_REF46","doi-asserted-by":"crossref","unstructured":"Seligmann M, Rambaud JC. Alpha-chain disease: a possible model for the pathogenesis of human lymphomas. In: Twomey JJ, Good RA, eds. Comprehensive Immunology: The ImmunoPathology of Lymphoreticular Neoplasms. New York, NY: Plenum; 1978: 425-427.","DOI":"10.1007\/978-1-4613-4015-7_14"},{"key":"2020021223121390800_REF47","doi-asserted-by":"crossref","unstructured":"Matuchansky C, Cogne M, Lemaire M, et al. Nonsecretory alpha-chain disease with immunoproliferative small-intestinal disease. N Engl J Med.1989;320: 1534-1539.","DOI":"10.1056\/NEJM198906083202307"},{"key":"2020021223121390800_REF48","unstructured":"Mestecky J, Blumberg RS, Kiyono H, McGhee JR. The mucosal immune system. In: Paul WC, ed. Fundamental Immunology. Philadelphia, PA: Lippincott, Williams & Wilkins; 2003: 965-971."},{"key":"2020021223121390800_REF49","doi-asserted-by":"crossref","unstructured":"Dackowski W, Morrison SL. Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases. Proc Natl Acad Sci U S A.1981;78: 7091-7905.","DOI":"10.1073\/pnas.78.11.7091"},{"key":"2020021223121390800_REF50","doi-asserted-by":"crossref","unstructured":"Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood. 2003;102: 1012-1018.","DOI":"10.1182\/blood-2002-11-3502"},{"key":"2020021223121390800_REF51","unstructured":"Pellet P, Berger R, Bernheim A, Brouet JC, Tsapis A. Molecular analysis of a t(9;14)(p11;q32) translocation occurring in a case of human alpha heavy chain disease. Oncogene. 1989;4: 653-657."},{"key":"2020021223121390800_REF52","doi-asserted-by":"crossref","unstructured":"Gafter U, Kessler E, Shabtay F, Shaked P, Djaldetti M. Abnormal chromosomal marker (D14 q+) in a patient with alpha heavy chain disease. J Clin Pathol.1980;33: 136-144.","DOI":"10.1136\/jcp.33.2.136"},{"key":"2020021223121390800_REF53","doi-asserted-by":"crossref","unstructured":"Chesi M, Kuehl WM, Bergsagel PL. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Ann Oncol.2000;11(suppl 1): 131-135.","DOI":"10.1093\/annonc\/11.suppl_1.S131"},{"key":"2020021223121390800_REF54","doi-asserted-by":"crossref","unstructured":"Nikbin B, Banisadre M, Ala F, Mojtabai A. HLA AW19, B12 in immunoproliferative small intestinal disease. Gut. 1979;20: 226-228.","DOI":"10.1136\/gut.20.3.226"},{"key":"2020021223121390800_REF55","doi-asserted-by":"crossref","unstructured":"Banihashemi A, Nasr K, Hedayatee H, Mortazavee H. Familial lymphoma including a report of familial primary upper small intestinal lymphoma. Blut.1973;26: 363-368.","DOI":"10.1007\/BF01632745"},{"key":"2020021223121390800_REF56","doi-asserted-by":"crossref","unstructured":"Peterson MC. Immunoproliferative small intestinal disease associated with Campylobacter jejuni [author reply appears in N Engl J Med. 2004;350: 1685-1686]. N Engl J Med.2004;350: 1685-1686.","DOI":"10.1056\/NEJM200404153501619"},{"key":"2020021223121390800_REF57","doi-asserted-by":"crossref","unstructured":"Al-Saleem TI. Evidence of acquired immune deficiencies in Mediterranean lymphoma: a possible aetiological link. Lancet. 1978;2: 709-712.","DOI":"10.1016\/S0140-6736(78)92705-8"},{"key":"2020021223121390800_REF58","doi-asserted-by":"crossref","unstructured":"Kharazmi A, Rezai MH, Abadi P, Nasr K, Haghighi P, Haghshenas M. T and B lymphocytes in alpha-chain disease. Br J Cancer. 1978;37: 48-54.","DOI":"10.1038\/bjc.1978.7"},{"key":"2020021223121390800_REF59","unstructured":"Lopez-Botet M, Chantar C, Plaza A, Abreu L, Kreisler M, de Landazuri MO. In vitro immune cell function in six cases of immunoproliferative small intestinal disease after long term remission. Clin Exp Immunol.1983;53: 663-671."},{"key":"2020021223121390800_REF60","doi-asserted-by":"crossref","unstructured":"Goossens T, Klein U, Kuppers R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A.1998;95: 2463-2468.","DOI":"10.1073\/pnas.95.5.2463"},{"key":"2020021223121390800_REF61","doi-asserted-by":"crossref","unstructured":"Hassane DC, Lee RB, Pickett CL. Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect Immun.2003;71: 541-545.","DOI":"10.1128\/IAI.71.1.541-545.2003"},{"key":"2020021223121390800_REF62","doi-asserted-by":"crossref","unstructured":"Akbulut H, Soykan I, Yakaryilmaz F, et al. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience. Cancer. 1997;80: 8-14.","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<8::AID-CNCR2>3.0.CO;2-T"},{"key":"2020021223121390800_REF63","doi-asserted-by":"crossref","unstructured":"Fischbach W, Tacke W, Greiner A, Konrad H, Muller H. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet. 1997;349: 31-32.","DOI":"10.1016\/S0140-6736(05)62165-4"},{"key":"2020021223121390800_REF64","doi-asserted-by":"crossref","unstructured":"Salimi M, Spinelli JJ. Chemotherapy of Mediterranean abdominal lymphoma: retrospective comparison of chemotherapy protocols in Iranian patients. Am J Clin Oncol.1996;19: 18-22.","DOI":"10.1097\/00000421-199602000-00004"},{"key":"2020021223121390800_REF65","doi-asserted-by":"crossref","unstructured":"Celik AF, Pamuk GE, Pamuk ON, Uzunismail H, Oktay E, Dogusoy G. Should we suppress the antigenic stimulus in IPSID for lifelong? Am J Gastroenterol.2000;95: 3318-3320.","DOI":"10.1111\/j.1572-0241.2000.03318.x"},{"key":"2020021223121390800_REF66","unstructured":"Rambaud J, Halphen M. Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and \u201cMediterranean\u201d lymphomas. Gastoenterol Int.1989;2: 33-41."},{"key":"2020021223121390800_REF67","doi-asserted-by":"crossref","unstructured":"el Saghir NS. Combination chemotherapy with tetracycline and aggressive supportive care for immunoproliferative small-intestinal disease lymphoma. J Clin Oncol.1995;13: 794-795.","DOI":"10.1200\/JCO.1995.13.3.794"},{"key":"2020021223121390800_REF68","unstructured":"Al-Saleem T. Pathology and time trend of the Mediterranean type of MALT lymphoma [abstract]. Proc 87th Ann Meeting Am Assoc Cancer Res, 1996; 255. Abstract no. 1738."},{"key":"2020021223121390800_","unstructured":"Selzer G, Sacks M, Sherman G, Naggan L. Primary malignant lymphoma of the small intestine in Israel: changing incidence with time. Isr J Med Sci.1979;15: 390-396."},{"key":"2020021223121390800_REF70","unstructured":"Almasri NM, al-Abbadi M, Rewaily E, Abulkhail A, Tarawneh MS. Primary gastrointestinal lymphomas in Jordan are similar to those in Western countries. Mod Pathol.1997;10: 137-141."},{"key":"2020021223121390800_REF71","doi-asserted-by":"crossref","unstructured":"Al-Attar A, Al-Mondhiry H, Al-Bahrani Z, Al-Saleem T. Burkitt's lymphoma in Iraq: clinical and pathological study of forty-seven patients. Int J Cancer. 1979;23: 14-17.","DOI":"10.1002\/ijc.2910230104"},{"key":"2020021223121390800_REF72","doi-asserted-by":"crossref","unstructured":"Nutt SL, Eberhard D, Horcher M, Rolink AG, Busslinger M. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int Rev Immunol.2001;20: 65-82.","DOI":"10.3109\/08830180109056723"},{"key":"2020021223121390800_REF73","doi-asserted-by":"crossref","unstructured":"Lin KI, Tunyaplin C, Calame K. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol Rev.2003;194: 19-28.","DOI":"10.1034\/j.1600-065X.2003.00040.x"},{"key":"2020021223121390800_REF74","doi-asserted-by":"crossref","unstructured":"Mahmoud MS, Huang N, Nobuyoshi M, Lisukov IA, Tanaka H, Kawano MM. Altered expression of Pax-5 gene in human myeloma cells. Blood. 1996;87: 4311-4315.","DOI":"10.1182\/blood.V87.10.4311.bloodjournal87104311"},{"key":"2020021223121390800_REF75","doi-asserted-by":"crossref","unstructured":"Avet-Loiseau H, Brigaudeau C, Morineau N, et al. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1999;24: 9-15.","DOI":"10.1002\/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO;2-K"},{"key":"2020021223121390800_REF76","doi-asserted-by":"crossref","unstructured":"Nair S, Mathan M, Ramakrishna BS, Mathan VI. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study. J Gastroenterol Hepatol.1998;13: 1207-1211.","DOI":"10.1111\/j.1440-1746.1998.tb00606.x"},{"key":"2020021223121390800_REF77","doi-asserted-by":"crossref","unstructured":"Isaacson PG, Dogan A, Price SK, Spencer J. Immunoproliferative small-intestinal disease: an immunohistochemical study. Am J Surg Pathol.1989;13: 1023-1033.","DOI":"10.1097\/00000478-198912000-00004"},{"key":"2020021223121390800_REF78","doi-asserted-by":"crossref","unstructured":"Yang HH, Ma MH, Vescio RA, Berenson JR. Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis. J Clin Oncol.2003;21: 4239-4247.","DOI":"10.1200\/JCO.2003.06.001"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/6\/2274\/1707696\/zh800605002274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/6\/2274\/1707696\/zh800605002274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T05:46:16Z","timestamp":1682833576000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/6\/2274\/20142\/Immunoproliferative-small-intestinal-disease-IPSID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,15]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-07-2755","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,15]]}}}